T1	Participants 289 441	low-risk patients who had coronary artery bypass grafting (CABG) and received full-dose systemic heparin did not have clearly improved clinical outcomes
T2	Participants 578 679	Three hundred fifty patients who had reoperation with CABG only (58%), or with valve operations (42%)
